IceCure, a medical device company that has developed cryoablation solutions for women's health, has raised $10.3 million in a public offering on the Tel Aviv Stock Exchange. IceCure was funded by
Giza Ventures and
Bridge Investment Fund of Cleveland. The Israeli company is exploring Cleveland as the location for its US headquarters. Roberts Mitani assisted with the financing.
Click here to read more from MedCity News.